Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Work In Process (2017 - 2025)

Dexcom (DXCM) has disclosed Work In Process for 12 consecutive years, with $105.0 million as the latest value for Q4 2025.

  • Quarterly Work In Process rose 273.67% to $105.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $105.0 million through Dec 2025, up 273.67% year-over-year, with the annual reading at $105.0 million for FY2025, 273.67% up from the prior year.
  • Work In Process for Q4 2025 was $105.0 million at Dexcom, up from $78.6 million in the prior quarter.
  • The five-year high for Work In Process was $105.0 million in Q4 2025, with the low at $13.6 million in Q2 2021.
  • Average Work In Process over 5 years is $40.3 million, with a median of $29.0 million recorded in 2023.
  • The sharpest move saw Work In Process dropped 12.97% in 2023, then surged 273.67% in 2025.
  • Over 5 years, Work In Process stood at $16.2 million in 2021, then increased by 6.17% to $17.2 million in 2022, then skyrocketed by 74.42% to $30.0 million in 2023, then fell by 6.33% to $28.1 million in 2024, then soared by 273.67% to $105.0 million in 2025.
  • According to Business Quant data, Work In Process over the past three periods came in at $105.0 million, $78.6 million, and $94.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.